CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q1 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $447,000 | -62.3% | 17,827 | -45.2% | 0.12% | -70.4% |
Q4 2021 | $1,185,000 | +278.6% | 32,550 | +543.4% | 0.41% | +112.6% |
Q4 2020 | $313,000 | -33.3% | 5,059 | -40.9% | 0.19% | -45.3% |
Q3 2020 | $469,000 | -1.3% | 8,559 | +3.6% | 0.35% | -41.9% |
Q2 2020 | $475,000 | – | 8,260 | – | 0.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
Birchview Capital, LP | 25,000 | $428,000 | 0.29% |